Fennec Pharma
在场
高管
查看带有其 11 名主要高管的组织结构图
Fennec Pharma 搜索最多的简介
- Jeffrey Hackman, Chief Executive Officer and Director
- Khalid Islam, Chairman of the Board
- Rostislav Raykov, Director
高管在Fennec Pharma变化
- Pierre Sayad已作为Chief Medical Officer加入公司 (新闻发布的2024十月30号).
- Terry Evans已作为Chief Commercial Officer加入公司 (新闻发布的2024十月30号).
- Christiana Cioffi已作为Chief Strategy Officer加入公司 (新闻发布的2024十月30号).
创建提醒
跟踪 Fennec Pharma 的高管变动
生物技术
Fennec Pharma 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Fennec Pharma 的最新新闻稿
- Fennec Announces Issuance of U.S. Patent for PEDMARK™ | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors | Fennec Pharmaceuticals In
- Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility | Fennec Pharmaceuticals Inc.
- Fennec Announces Results of Annual Meeting | Fennec Pharmaceuticals Inc.
- Press Releases | Investor Relations | Fennec Pharmaceuticals Inc.
- Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares | Fennec Pharmaceuticals Inc.
- Fennec Announces Closing of Public Offering | Fennec Pharmaceuticals Inc.
- Fennec Announces Pricing of Public Offering | Fennec Pharmaceuticals Inc.
- View more press releases Close
